Parasite evolution and impact in action: assessing the importance of hybrid schistosomes in Africa

03 - 04 February 2025 09:00 - 17:00 The Royal Society Free Watch online
Register now
Picture of a parasite

Science+ meeting organised by Professor J Russell Stothard, Professor Janelisa Musaya, Dr Alexandra Juhasz, and Dr Lucas Cunningham.

This meeting brings together various international groups and experts to discuss the biological, clinical and evolutionary importance of several newly described hybrids of Schistosoma haematobium in sub-Saharan Africa. Embracing a 'OneHealth' perspective, our discussions will focus upon the underlying mechanism that facilitate the emergence and dispersion of hybrids, considering their additional clinical impact in urogenital disease of children and adults.

The schedule, speaker biographies, and abstracts will be available closer to the meeting date.

Open abstract submissions

There will be an opportunity to give a short talk on either the Monday or Tuesday for 15 minutes as part of the meeting. If you would like to submit an open abstract, please submit your name, biography, proposed title, and abstract (up to 200 words) to the Scientific Programmes team no later than Monday 25 November 2024. 

Poster session

There will be a poster session on Monday 3 February 2025. If you would like to present a poster, please submit your proposed title, abstract (up to 200 words), author list, and the name of the proposed presenter and institution to the Scientific Programmes team no later than Monday 6 January 2025. 

Attending the meeting

This event is intended for researchers in relevant fields.

  • Free to attend

  • Both in-person and online attendance available. Advance registration is essential. Please follow the link to register

  • Lunch is available on both days of the meeting for an optional £25 per day. There are plenty of places to eat nearby if you would prefer to purchase food offsite. Participants are welcome to bring their own lunch to the meeting

Enquiries: Scientific Programmes team.

Organisers

  • Professor J Russell Stothard

    Professor J Russell Stothard

    Professor Stothard is a medical parasitologist with focus on helminth and protist parasites grouped within the neglected tropical diseases. His specialist expertise is in the evolution, epidemiology and control of schistosomiasis having undertaken many multidisciplinary studies from schistosome characterisation to snail ecology. In so doing, he has advanced our understanding of natural transmission cycles of key species of schistosome and their freshwater intermediate snail hosts. Such knowledge typically underpins scientific guidance to better tailor future disease control strategies and specific intersectoral interventions. His research has been translated into several international policy changes, presenting, co-chairing and chairing several expert committees of the World Health Organisation.

Schedule

Chair

Janelisa Musaya

Professor Janelisa Musaya

Kamuzu University of Health Sciences, Malawi

Professor J Russell Stothard

Professor J Russell Stothard

Liverpool School of Tropical Medicine

09:05-09:30 An introduction to the importance of hybrid schistosomes in Africa

In Africa there are two main species of human schistosome, Schistosoma haematobium and Schistosoma mansoni that give rise to urogenital schistosomiasis and intestinal schistosomiasis, respectively. Each schistosome species is a waterborne parasite firmly tied to certain species of freshwater gastropod snails. Infections with schistosomes can start very early in life and, depending on the transmission setting, exposure to these blood flukes is an unavoidable risk of daily life. In addition to these schistosome species, there are several others that infect a variety of wild and/or domesticated mammals. Species of the latter are significant scourges of livestock health and food security yet are not given sufficient veterinary attention. A recently appreciated feature of the reproductive biology of all schistosomes is their capacity for cross-specific interaction, which may, or may not, lead onto the formation of viable hybrids. These saltatory steps in evolution can be between either closely- or distantly-related forms. Heterosis, or hybrid vigour, is a peculiar feature to hybrid schistosomes that may raise their ability to cause disease or expand their range to areas where their parental species cannot. Effective methods used to control such hybrids needs a detailed One Health appraisal. As our understanding of schistosome hybridisation is incomplete, Professor Stothard will give an introductory overview of this scientific meeting’s objectives, a brief outline of critical knowledge gaps with a few considered pointers for subsequent general discussion and deliberation.

Professor J Russell Stothard

Professor J Russell Stothard

Liverpool School of Tropical Medicine

09:30-09:45 Short talk - open

If you would like to submit an abstract, please contact the Scientific Programmes team. 

09:45-10:15 An incomplete historical perspective on the molecular detection of schistosome hybrids

The advancement in molecular methods allowed to study phenomena like hybridisation and introgression at a very detailed level. This resulted in the demonstration of hybridisation between schistosome species in the field, in diverse ecological settings and involving different species combinations. In this talk, Tine Huyse will present some of the first studies on the molecular detection of schistosome hybrids in Africa, and how they evolved over time. Both clinical studies and epidemiological field studies will be presented, with a final reflection on opportunities and challenges. 

Dr Tine Huyse

Dr Tine Huyse

Royal Museum for Central Africa, Belgium

10:15-10:30 Short talk - open

If you would like to submit and abstract, please contact the Scientific Programmes team. 

10:30-11:00 Break
11:00-11:30 Reservoir host or not, that is the question…

We have known that distinct Schistosoma species are capable of hybridisation since the 1950s, but it was not until 2009 and the discovery of hybrids between S. haematobium and S. bovis in humans that there were fears of zoonotic urogenital bilharziasis. Then, the interest in these hybrids has grown since their emergence in Europe in 2013. One major question is the zoonotic capacity of these hybrids. The various studies from the laboratory to the field are not consensual. The aim of this presentation will be to review the evidence for and against the zoonotic nature of urogenital bilharziasis. A number of avenues will also be explored to shed light on this issue.

Professor Jerome Boissier

Professor Jerome Boissier

Université de Perpignan, France

11:30-11:45 Short talk - open

If you would like to submit an abstract, please contact the Scientific Programmes team. 

11:45-12:15 Importance of interactions and hybridisations in schistosomes in Cameroon

Across Africa, human schistosomiasis is caused by four Schistosoma species (S. mansoni, S. haematobium, S. guineensis and S. intercalatum) coexisting alongside with several species associated with animals (eg S. bovis and S. curassoni). Three of these four human schistosome-species occur in Cameroon: S. haematobium and S. mansoni are widely distributed across the country, whereas S. guineensis has a very restricted distribution. Our studies on interactions between these schistosome species have revolutionised general understanding by demonstrating: the existence of a choice of mate in mixed infections, the mating competition between species, the competitive exclusion, the heterosis, and the introgressive hybridisation. The increasing reports of hybrids between human and animal schistosome species in several parts of Africa are very worrisome. These multispecies interactions and hybridisations have significant impacts on schistosome epidemiology, transmission and disease control, with several under-appreciated factors. Our current research on hybrid schistosomes will contribute to elucidate gaps in knowledge of interactions between human and animal schistosome species in Cameroon, especially within the S. haematobium group. Louis-Albert Tchuem Tchuenté will present some of our major findings and provide an overview of our ongoing SHIS-CAM research project on species hybridisation and interactions in schistosomes in Cameroon, within the context of One Health.

Louis-Albert Tchuem Tchuenté

Louis-Albert Tchuem Tchuenté

University of Yaoundé I, Cameroon

12:15-12:30 Short talk - open

If you would like to submit an abstract, please contact the Scientific Programmes team. 

Chair

Professor Joanne P Webster FMedSci

Professor Joanne P Webster FMedSci

Royal Veterinary College, UK

Dr Lucas Joseph Cunningham

Dr Lucas Joseph Cunningham

Liverpool School of Tropical Medicine

13:30-14:00 Hybridisation in urogenital schistosomiasis: a public health challenge in Malawi

Schistosomiasis remains a pressing public health concern in Malawi, compounded by the emergence of hybrid species between Schistosoma. haematobium (human-specific) and Schistosoma matthaei (animal specific). These hybrids, identified in recent studies under the Hybridization in Urogenital Schistosomiasis (HUGS) project, were confirmed in 7% of the communities in Mangochi and Nsanje districts. These hybrids exhibit atypical egg shedding patterns, complicating traditional diagnosis and treatment while raising concerns about potential drug resistance and increased morbidity, particularly among women experiencing Female Genital Schistosomiasis (FGS), highlighting the need for molecular diagnostic tools to accurately identify infections.

The zoonotic potential of hybrids broadens the transmission reservoir, incorporating livestock and intensifying risks in communities dependent on shared water sources for domestic and livelihood activities. This heightened human-animal interface complicates control efforts, particularly in endemic areas where water contact is unavoidable. This presentation delves into findings from the HUGS project, addressing the clinical and zoonotic challenges posed by hybrid schistosomes. It advocates for a One Health approach, integrating human and animal health sectors to enhance diagnostic capacity, develop tailored treatment protocols, and promote community awareness (and involvement in preventive and control) initiatives. These strategies are vital for mitigating the public health burden of hybrid schistosomiasis and advancing Malawi’s efforts toward sustainable disease control.

Professor Janelisa Musaya

Professor Janelisa Musaya

Kamuzu University of Health Sciences, Malawi

14:00-14:15 Short talk - open

If you would like to submit an abstract, please contact the Scientific Programmes team. 

14:15-14:45 Hybrids in genital tract disease: genital schistosomiasis caused by hybrids in men and women of endemic areas of Southern Malawi in Sub Saharan Africa

Genital schistosomiasis (GS) remains an ignored consequence of urogenital schistosomiasis in the genital system of men and women. However, this is not fully described in infections caused by hybrid schistosomes. Among the research studies conducted on GS, we described a Hybridisation of UroGenital Schistosomiasis (HUGS) longitudinal sub-study on male and female genital schistosomiasis (MGS and FGS) caused by hybrids, conducted in Southern Malawi.

Following demographic, health and socio-economic data collection, urine, cervicovaginal fluid, swabs and semen samples were collected and analysed to determine schistosome infection. Samples also underwent molecular analysis to detect human, zoonotic and hybrid schistosomes. Colposcopy and histopathology were also conducted while other associated infections (Human papilloma virus (HPV) and sexually transmitted infections (STIs) were also screened.

Dr Sekeleghe Kayuni

Dr Sekeleghe Kayuni

Malawi Liverpool Wellcome Clinical Research Programme, Malawi

14:45-15:00 Short talk - open

If you would like to submit an abstract, please contact the Scientific Programmes team. 

15:00-15:30 Break
15:30-16:00 Genital schistosomiasis: are we missing something?

Urogenital schistosomiasis is a disease caused mainly by the human parasite, Schistosoma haematobium. The downstream manifestations of the disease, particularly pertaining to the genital track, can be disabling and often go unrecognised, as they are confounded by symptoms commonly related to sexually transmitted diseases. The sexual and reproductive life of the disease sufferers can be affected with an increase in infertility, ectopic pregnancies and abnormal pain and bleeding. An upsurge in advocacy efforts has increased the global interest and recognition of female and male genital schistosomiasis (FGS/MGS) as some of the most neglected genital disorders. Modern diagnostic approaches are refining burden of disease estimates and new questions are emerging on the potential impact of schistosome hybrids and animal species on disease manifestations and respond to treatment. Professor Bustinduy will give an introductory overview of both FGS/MGS and the different diagnostic and treatment strategies available with a special emphasis on gaps in knowledge and potential novel research approaches considering zoonotic species and hybrids.

Professor Amaya L Bustinduy

Professor Amaya L Bustinduy

London School of Hygiene & Tropical Medicine

16:00-16:15 Short talk - open

If you would like to submit an abstract, please contact the Scientific Programmes team. 

16:15-16:45 The hybrid conundrum!

Inter-species Schistosoma hybrids blur the lines between human and animal African schistosomiasis, creating worrying scenarios of animal reservoirs of human infections and the occurrence of zoonotic species, all of which could severely compromise schistosomiasis control efforts.

Molecular and genomic tools have been instrumental in uncovering the different hybrid forms in multiple geographical areas. However, gaps remain in our understanding of the evolutionary history of these hybrid forms, their impact on human and animal health and moreover what further research is needed to fully understand the extent of the permeability of the pre- and post-zygotic barriers that are either maintaining or dissolving species integrity.

This presentation will take a step back to look at the African Schistosoma species in terms of their taxonomic status, whilst discussing the opportunities they encounter to enable inter-species mixing / hybridisation, together with the potential outcomes. I will also discuss the biases we observe within the different Schistosoma hybridisation systems now identified in Africa, how best to interpret these so that we better understand what inter-species hybridisation may mean in terms of human schistosomiasis control and elimination in Africa.

Dr Bonnie Webster

Dr Bonnie Webster

Natural History Museum, UK

16:45-17:00 Panel discussion

Chair

Professor Amaya Bustinduy

Professor Amaya L Bustinduy

London School of Hygiene & Tropical Medicine

Dr Sekeleghe Kayuni

Dr Sekeleghe Kayuni

Malawi Liverpool Wellcome Clinical Research Programme, Malawi

09:00-09:30 Schistosome hybridisation: many questions and a few answers!

How common is hybridisation in schistosome populations? What are the genomic consequences of hybridisation? Does hybridisation result in transfer of important traits between species? How can we characterize hybridisation in natural parasite populations? What are the implications for schistosome control? Professor Tim Anderson's laboratory has analysed genome sequence of Schistosoma bovis and Schistosoma haematobium genomes from multiple countries across Africa providing a genomic perspective on these questions using one species pair of particular interest.

Professor Tim Anderson

Professor Tim Anderson

Texas Biomedical Research Institute, USA

09:30-09:45 Short talk - open

If you would like to submit an abstract, please contact the Scientific Programmes team. 

09:45-10:15 Parasite evolution and impact in action: schistosoma spp. hybridisation in West Africa

Since 2021 we have seen the launch of a new WHO Neglected Tropical Diseases (NTD) Roadmap, together with revised Disease Control and Elimination Guidelines and Targets for schistosomiasis. Across all there is now a clear emphasis on the need to incorporate a One Health approach, recogniSing the critical links between human and animal health and the environment.  Whilst animal hosts have been long acknowledged as zoonotic reservoirs across Asia, within Africa or the Americas, in contrast, any zoonotic component of schistosomiasis transmission and its implications for disease control has, until recently, been largely ignored.  This is true of both S. mansoni, but also notably, S. haematobium, the latter of which was assumed to be an exclusively human infection – and thus amenable to elimination (so long as no drug resistance evolves) by targeting treatment of humans alone. However, an increasing body of work has revealed widespread viable hybridization between S. haematobium of humans with Schistosoma spp. (notably S. bovis, S. curassoni or S. mattheii) of livestock and wildlife throughout Africa and beyond. The dynamics of which species/species-combination predominates varies focally.  Moreover, whilst recent genomic evidence suggests the majority of such hybrids are ancient, there is also evidence of rare ongoing contemporary hybridisation. Here I will present some of our recent research focusing on the transmission dynamics of Schistosoma spp. within Senegal and Niger. 

Professor Joanne P Webster FMedSci

Professor Joanne P Webster FMedSci

Royal Veterinary College, UK

10:15-10:30 Short talk - open

If you would like to submit an abstract, please contact the Scientific Programmes team. 

10:30-11:00 Break
11:00-11:30 Prevalence and zoonotic potential of hybrid schistosomes in cattle and goats in Malawi: a case study in Chimbende

Schistosomiasis transmission involving Schistosoma haematobium-mattheei hybrids has emerged in Malawi, presenting notable zoonotic implications. Our previous studies have documented hybrid schistosome infections in cattle and goats, revealing spatial variation and environmental influences on infection rates. In Mangochi District, cattle were found to have a schistosomiasis prevalence of 49.1%, with a small proportion shedding S. haematobium-mattheei hybrids in Chimbende. GPS tracking and praziquantel efficacy studies highlighted the role of Lake Malawi as a focal water source contributing to reinfection among cattle. Similarly, a caprine schistosomiasis survey across three districts found S. mattheei infection rates in goats of up to 25.3% in Mangochi, with evidence of zoonotic transmission from S. haematobium in Chikwawa.

Expanding on these findings, we conducted a case study in Chimbende to examine hybrid schistosome prevalence in 15 sleeping kraals from cattle small holders. Although our case example investigated 80 cattle at Chimbende in much greater detail it did not re-encounter hybrid infections. This highlights the more ephemeral dynamics of hybrids most likely within younger animals. However, the presence of zoonotic and hybrid schistosomes in Malawi emphasises the need for integrated control efforts that address both animal and human transmission pathways. Future management should incorporate targeted praziquantel treatment, ongoing snail host surveillance, and One Health strategies to mitigate zoonotic spillover and support sustainable schistosomiasis control in Malawi.

Dr Alexandra Juhasz

Dr Alexandra Juhasz

Liverpool School of Tropical Medicine, UK

11:30-11:45 Short talk - open

If you would like to submit an abstract, please contact the Scientific Programmes team. 

11:45-12:15 Modelling insights: zoonotic spillover and hybridisation of Haematobium group schistosome transmission dynamics at the human-animal interface

Zoonotic spillover together with hybridisation of parasites are major emerging public and veterinary health concerns at the interface of infectious disease biology, evolution, and control. Combining model-based approaches and analyses of parasitological, molecular, and epidemiological data from northern Senegal, a region with a high prevalence of schistosome hybrids, we aimed to unravel the transmission dynamics of this complex multi-host, multi-parasite system. Using Bayesian methods and by estimating the basic reproduction number (R0), we evaluate the frequency of zoonotic spillover of Schistosoma bovis from livestock and the potential for onward transmission of hybrid S bovis × S haematobium offspring within human populations. We estimate R0 of hybrid schistosomes to be greater than the critical threshold of one (1.76; 95% CI 1.59 to 1.99), demonstrating the potential for hybridisation to facilitate spread and establishment of schistosomiasis beyond its original geographical boundaries. We estimate R0 for S bovis to be greater than one in cattle (1.43; 95% CI 1.24 to 1.85) but not in other ruminants, confirming cattle as the primary zoonotic reservoir. Through longitudinal simulations, we also show that where S bovis and S haematobium are coendemic (in livestock and humans respectively), the relative importance of zoonotic transmission is predicted to increase as the disease in humans nears elimination. Finally, we consider how quantitative approaches may provide new insights into the morbidity impact of an increasing prevalence of hybrid schistosome. 

Dr Anna Borlase

Dr Anna Borlase

University of Oxford, UK

Chair

Professor J Russell Stothard

Professor J Russell Stothard

Liverpool School of Tropical Medicine

Dr Alexandra Juhasz

Dr Alexandra Juhasz

Liverpool School of Tropical Medicine, UK

13:30-14:00 Epidemiology of schistosoma haematobium hybrids: probing host age, sex, and household location in Southern Malawi

Schistosomiasis is best known as an anthroponotic disease most commonly caused by S. mansoni and S. haematobium, with the latter two responsible for the majority of global cases, over 90% of which occur in sub-Saharan Africa. Less recognised are zoonotic species of Schistosoma, particularly the sister species of S. haematobium, which infect domesticated Bovidae. However, due to the close phylogenetic relationship between anthroponotic and zoonotic species, of the S. haematobium group, hybridisation readily occurs. Despite the growing number of schistosomiasis cases that implicate these zoonotic species in humans, our understanding of their prevalence in local communities and transmission patterns is incomplete. 

This gap in our understanding spurred the Hybridisation in UroGenital Schistosomiasis (HUGS) study in Southern Malawi's Mangochi and Nsanje districts. Over three years, this study investigated the prevalence and risk factors associated with zoonotic and hybrid schistosome infections in humans through annual urine screening using microscopy and novel, high-throughput, HRM qPCR assays capable of putative identification of zoonotic and hybrid schistosomes. Approximately 1,000 participants from each district were enrolled annually, yielding over 6,000 samples. Among these, 208 samples tested positive for zoonotic S. mattheei, with 37 cases in Nsanje and 171 in Mangochi. One putative mixed infection involving S. bovis and S. haematobium was also identified.
This research highlights zoonotic schistosomiasis's significant, yet underappreciated, role in human infection. Here, we present further analysis of these findings at the household level, exploring associations with sex and age demographics in the studied communities.

Dr Lucas Joseph Cunningham

Dr Lucas Joseph Cunningham

Liverpool School of Tropical Medicine

14:00-14:15 Short talk - open

If you would like to submit an abstract, please contact the Scientific Programmes team. 

14:15-14:45 Learnings in schistosomiasis drug discovery
Dr Thomas Spangenberg

Dr Thomas Spangenberg

Merck Healthcare KGaA

14:45-15:15 Elimination of schistosomiasis as public health problem in Africa: progress and challenges

Schistosomiasis remains a significant global public health problem. The control of schistosomiasis is based on integrated approaches combining large-scale treatment of at-risk population groups, access to safe water, improved sanitation, hygiene education and behavior change, and snail control and environmental management. 

Following the 2012 World Health Assembly resolution 65.21 and the London Declaration on Neglected Tropical Diseases (NTD) and the first NTD roadmap, endemic countries implemented large-scale programmes to control and eliminate the disease. The second World Health Organisation Roadmap for NTDs 2021-2030 went further, setting the goal of global elimination of schistosomiasis as a public health problem and elimination of transmission in selected countries.

Schistosomiasis is endemic in 78 countries and territories, with 254 million people needing treatment by 2023 in 50 countries with moderate to high transmission. The African Region has the highest burden, with 91% of people requiring preventive chemotherapy for schistosomiasis living in this region. Between 2006 and 2023, 952 million treatments were provided through mass campaigns in Africa. This has resulted in a 60% reduction in the prevalence of schistosomiasis over the last 10 years. 

Progress towards elimination requires country ownership and implementation of programmes in line with guidelines for targeted treatment and provision of a comprehensive package of interventions, including impact assessment and a strong surveillance system, including snail control and case tracking. However, there are many challenges on the road to elimination, such as integration into the health system, dwindling financial resources, and the need to develop new interventions.

Amadou Garba Djirmay

Amadou Garba Djirmay

World Health Organisation, Switzerland

15:15-15:45 Break
15:45-17:00 Open short talk prize
Professor Sir Roy Anderson FMedSci FRS

Professor Sir Roy Anderson FMedSci FRS

Imperial College London, UK

Professor J Russell Stothard

Professor J Russell Stothard

Liverpool School of Tropical Medicine

Professor Janelisa Musaya

Professor Janelisa Musaya

Kamuzu University of Health Sciences, Malawi